About 500mg Tenvir EM Tenofovir Disoproxil Fumarate Emtricitabine Tablets
| Strength |
300mg + 200mg |
| Brand |
Tenvir-EM |
| Composition |
Tenofovir Disoproxil Fumarate + Emtricitabine |
| Form |
Tablet |
| Prescription/Non prescription |
Prescription |
| Treatment |
HIV infection |
| Packaging Size |
30 Tablets |
| Manufacturer |
Cipla Ltd |
Tenvir-EM Tablet is a combination of two anti-HIV medicines: Emtricitabine and Tenofovir disoproxil fumarate. They prevent HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.
Trusted Antiviral Protection for HIVTenvir-EM serves dual roles-both in preventing HIV infection (PrEP) in high-risk adults and as part of combination therapy for HIV-1 treatment. With proven efficacy and US FDA-approved ingredients, this medicine has earned WHO prequalification, endorsing its safety and quality for global health applications.
Simple Dosing and AdministrationTaking Tenvir-EM is straightforward: swallow one tablet daily, with or without food, as your healthcare provider directs. Do not miss doses, and always adhere to your physician's guidance. Regular follow-up with your doctor ensures safety and effectiveness throughout your therapy.
Clear Identification and ComplianceEach tablet is blue, capsule-shaped, and marked with 'TENOFOVIR/EMTRICITABINE' for easy identification. Supplied as a box of 30 tablets, it supports a consistent one-month supply. Store below 30C, in a dry place, and keep away from direct sunlight to maintain efficacy.
FAQ's of 500mg Tenvir EM Tenofovir Disoproxil Fumarate Emtricitabine Tablets:
Q: What is Tenvir-EM used for?
A: Tenvir-EM is indicated for the treatment and prevention of HIV-1 infection. It is used as part of antiretroviral therapy and as pre-exposure prophylaxis (PrEP) in adults at substantial risk of HIV-1 infection.
Q: How should Tenvir-EM tablets be taken?
A: The recommended dosage is one tablet daily, taken orally with or without food, exactly as prescribed by your healthcare provider. Do not skip doses, and consult your doctor for ongoing monitoring.
Q: Who should not take Tenvir-EM?
A: Tenvir-EM should not be used by individuals with known hypersensitivity to any of its components, those with severe renal impairment, or by persons under 18 years old. Medical supervision is essential before starting therapy.
Q: What side effects may occur with Tenvir-EM?
A: Common side effects include nausea, headache, and fatigue. Potentially, it may cause renal or bone effects. Notify your healthcare provider if you experience persistent or severe symptoms.
Q: Where should Tenvir-EM tablets be stored?
A: Store the tablets below 30C, protected from moisture and light, in their original packaging. Keep them out of reach of children and dispose of unused tablets following local pharmaceutical waste regulations.
Q: When should I start or stop using Tenvir-EM for HIV prevention?
A: Tenvir-EM should always be started or discontinued under the guidance of a healthcare professional, based on individual risk and laboratory assessments. Do not stop taking the medication abruptly without medical advice.
Q: What are the benefits of using Tenvir-EM for PrEP?
A: When taken consistently, Tenvir-EM significantly reduces the risk of acquiring HIV-1 infection in adults at high risk, providing an effective preventive option as part of a comprehensive HIV prevention strategy.